1. Home
  2. STGW vs ABCL Comparison

STGW vs ABCL Comparison

Compare STGW & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stagwell Inc.

STGW

Stagwell Inc.

HOLD

Current Price

$6.89

Market Cap

1.7B

Sector

N/A

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$5.19

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STGW
ABCL
Founded
1980
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
STGW
ABCL
Price
$6.89
$5.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
$8.39
$8.40
AVG Volume (30 Days)
1.4M
6.5M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
$2,909,000,000.00
$75,128,000.00
Revenue This Year
$13.27
N/A
Revenue Next Year
$4.07
$21.85
P/E Ratio
N/A
N/A
Revenue Growth
2.39
160.56
52 Week Low
$4.29
$2.75
52 Week High
$7.52
$6.79

Technical Indicators

Market Signals
Indicator
STGW
ABCL
Relative Strength Index (RSI) 57.25 49.96
Support Level $4.94 $3.42
Resistance Level $7.02 $5.63
Average True Range (ATR) 0.31 0.54
MACD -0.00 -0.12
Stochastic Oscillator 53.94 9.83

Price Performance

Historical Comparison
STGW
ABCL

About STGW Stagwell Inc.

Stagwell Inc is a challenger network using AI to deliver marketing and advertising solutions to its clients. It operates in five reportable segments: Marketing Services, Digital Transformation, Media and Commerce, Communications, and The Marketing Cloud. Maximum revenue is generated from the Marketing Services segment, which offers social media solutions, designs breakthrough brand campaigns, and creates immersive experiential marketing programs and social engagement strategies, helping clients connect with audiences across digital platforms. The various brands operating under this segment include 72 and Sunny, Anomaly, NRG, Harris Insights, TEAM, and Movers & Shaker. Geographically, the company generates maximum revenue from the United States, followed by the UK and other countries.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: